Senior insider sale
SVP, CRO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$5.43M
11.57K shares
What this filing means
TATSIS OURANIA plans to sell 11.57K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $5.43M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001959173-26-001046
Officer· SVP, CRO
Since Oct 2019
11.57K
Shares to sell
$5.43M
Approx. market value
609.00
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/13/2026
609.00Total acquired609.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2026 | Restricted Stock Vesting Compensation | 609.00 | — |
| Total | 609.00 | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.50K
Market value
$750.0K
2/13/2026
—Completed
Units to sell
466.00
Market value
$214.6K
2/11/2026
—Completed
Units to sell
4.50K
Market value
$2.14M
1/7/2026
—Completed
Units to sell
4.50K
Market value
$2.02M
12/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
609.00
Market value
$298.1K
2/17/2026
Total
Units
11.57K
Value
$5.43M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/13/2026 | 1.50K | $750.0K | — | Completed |
2/11/2026 | 466.00 | $214.6K | — | Completed |
1/7/2026 | 4.50K | $2.14M | — | Completed |
12/3/2025 | 4.50K | $2.02M | — | Completed |
| Planned — Approximate Date | ||||
2/17/2026 | 609.00 | $298.1K | NASDAQ | Planned |
| Total | 11.57K | $5.43M | ||